Renvela

DRUG3 trials

Sponsors

Helse Stavanger HF, Ardelyx, Chugai Pharmaceutical

Conditions

HealthyHyperphosphatemiaKidney Failure

Phase 1

A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722

CompletedNCT02346890

Start: 2013-04-30End: 2013-04-30Updated: 2015-01-27

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

CompletedNCT02965053

Chugai PharmaceuticalHyperphosphatemia

Start: 2016-12-31End: 2018-08-31Updated: 2018-09-13

Phase 2

Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder.

CompletedNCT01231438

Helse Stavanger HFKidney Failure

Start: 2010-10-31End: 2011-03-31Updated: 2012-11-09

Related Papers

Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders

Clinical Pharmacology in Drug Development2016-09-2218 citations

Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial.

2012-06-2814 citations